Leveraging exploratory investigational new drug studies to accelerate drug development

scientific article published on 01 June 2008

Leveraging exploratory investigational new drug studies to accelerate drug development is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/1078-0432.CCR-07-4558
P698PubMed publication ID18559581

P2093author name stringGeorge Mills
David Jacobson-Kram
P433issue12
P304page(s)3670-3674
P577publication date2008-06-01
P1433published inClinical Cancer ResearchQ332253
P1476titleLeveraging exploratory investigational new drug studies to accelerate drug development
P478volume14

Reverse relations

cites work (P2860)
Q33819361Accelerator mass spectrometry-enabled studies: current status and future prospects
Q43101328Advancing radiology through informed leadership: summary of the proceedings of the Seventh Biannual Symposium of the International Society for Strategic Studies in Radiology (IS(3)R), 23-25 August 2007.
Q37358487Phase 0 clinical studies in oncology
Q34941964Phase 0 clinical trials in oncology new drug development
Q84400479Phase 0 exploratory clinical trials: literature review 2006-2009
Q50871327To Apply Microdosing or Not? Recommendations to Single Out Compounds with Non-Linear Pharmacokinetics

Search more.